Metasphere Labs Inc.
LABZ
CNSX
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -44.69% | -24.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -44.69% | -24.21% | |||
| Operating Income | 50.14% | 15.93% | |||
| Income Before Tax | 59.99% | -33.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 59.99% | -33.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.99% | -33.99% | |||
| EBIT | 50.14% | 15.93% | |||
| EBITDA | -- | 16.40% | |||
| EPS Basic | 60.62% | -26.14% | |||
| Normalized Basic EPS | 44.71% | 11.46% | |||
| EPS Diluted | 60.62% | 31.32% | |||
| Normalized Diluted EPS | 44.71% | 11.46% | |||
| Average Basic Shares Outstanding | 1.92% | 5.91% | |||
| Average Diluted Shares Outstanding | 1.92% | 5.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||